Wockhardt Limited
NSE:WOCKPHARMA.NS
1236.3 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 27,980 | 26,510 | 32,100 | 26,992.1 | 28,330.3 | 41,399.4 | 39,369 | 40,146.1 | 44,614.3 | 44,815.4 | 48,303.6 | 56,094.2 | 46,138 | 37,512.39 | 45,014.22 | 35,925.59 | 26,531.54 | 17,290.39 | 14,130.35 |
| Cost of Revenue
| 20,170 | 11,110 | 12,670 | 11,354.9 | 12,034.5 | 18,146.3 | 17,975.3 | 16,620.7 | 16,042.1 | 14,874.8 | 18,062.5 | 17,475.6 | 18,378.7 | 15,162.22 | 19,725.37 | 13,404.35 | 9,927.52 | 6,678.49 | 5,771.36 |
| Gross Profit
| 7,810 | 15,400 | 19,430 | 15,637.2 | 16,295.8 | 23,253.1 | 21,393.7 | 23,525.4 | 28,572.2 | 29,940.6 | 30,241.1 | 38,618.6 | 27,759.3 | 22,350.17 | 25,288.85 | 22,521.24 | 16,604.02 | 10,611.9 | 8,358.99 |
| Gross Profit Ratio
| 0.279 | 0.581 | 0.605 | 0.579 | 0.575 | 0.562 | 0.543 | 0.586 | 0.64 | 0.668 | 0.626 | 0.688 | 0.602 | 0.596 | 0.562 | 0.627 | 0.626 | 0.614 | 0.592 |
| Reseach & Development Expenses
| 1,320 | 1,410 | 1,430 | 1,724.5 | 2,080.9 | 2,908.6 | 2,872 | 3,971.3 | 9,955.2 | 4,887 | 4,030.4 | 8,270.7 | 537.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,050 | 1,100 | 1,480 | 1,353 | 1,024 | 2,235 | 2,692.5 | 3,031.5 | 2,060.9 | 1,399.6 | 795.7 | 1,020.4 | 2,673.2 | 0 | 0 | 0 | 0 | 116.95 | 89.92 |
| Selling & Marketing Expenses
| 1,250 | 1,340 | 1,800 | 1,316.2 | 1,411.8 | 2,389.8 | 2,088.9 | 2,053 | 2,586.7 | 2,615.5 | 2,929.8 | 2,917.4 | 2,124.4 | 0 | 0 | 0 | 0 | 1,066.73 | 830.79 |
| SG&A
| 8,340 | 2,440 | 3,280 | 2,669.2 | 2,435.8 | 4,624.8 | 4,781.4 | 5,084.5 | 4,647.6 | 4,015.1 | 3,725.5 | 3,937.8 | 4,797.6 | 0 | 0 | 0 | 0 | 1,183.68 | 920.71 |
| Other Expenses
| -140 | 14,460 | 15,640 | 15,776.5 | 15,123.8 | 24.2 | 231.3 | 103.6 | 20,167.7 | 19,108.5 | 18,116.5 | 15,006.7 | 9,123 | 1,366.57 | -527.6 | -1,303.92 | 10,888.25 | 9,553.46 | 7,159.18 |
| Operating Expenses
| 8,480 | 16,900 | 18,920 | 18,445.7 | 17,559.6 | 23,564 | 23,443.3 | 24,752.5 | 24,815.3 | 23,123.6 | 21,842 | 18,944.5 | 14,458.5 | 14,270.06 | 18,243.57 | 15,161.47 | 10,888.25 | 10,737.14 | 8,079.89 |
| Operating Income
| -670 | -280 | 540 | -2,663.9 | -931.7 | -310.9 | -2,049.6 | -1,227.1 | 3,756.9 | 6,817 | 8,399.1 | 19,674.1 | 13,300.8 | 8,080.11 | 7,045.28 | 7,359.77 | 5,715.77 | -125.24 | 279.1 |
| Operating Income Ratio
| -0.024 | -0.011 | 0.017 | -0.099 | -0.033 | -0.008 | -0.052 | -0.031 | 0.084 | 0.152 | 0.174 | 0.351 | 0.288 | 0.215 | 0.157 | 0.205 | 0.215 | -0.007 | 0.02 |
| Total Other Income Expenses Net
| -3,530 | -5,960 | -4,650 | -3,019.5 | -2,488.7 | -2,692.3 | -4,361.9 | -1,244.4 | -186.8 | -1,063.6 | 507.6 | -1,297.2 | -7,533.6 | -7,036.62 | -16,901.64 | -9,869.37 | -974.29 | 3,066.96 | 2,665.97 |
| Income Before Tax
| -4,200 | -6,240 | -4,110 | -5,683.4 | -3,420.4 | -3,003.2 | -6,411.5 | -2,471.5 | 3,570.1 | 5,753.4 | 8,906.7 | 18,376.9 | 5,767.2 | 1,043.49 | -9,856.36 | -2,509.6 | 4,741.48 | 2,941.72 | 2,945.07 |
| Income Before Tax Ratio
| -0.15 | -0.235 | -0.128 | -0.211 | -0.121 | -0.073 | -0.163 | -0.062 | 0.08 | 0.128 | 0.184 | 0.328 | 0.125 | 0.028 | -0.219 | -0.07 | 0.179 | 0.17 | 0.208 |
| Income Tax Expense
| 520 | -30 | -1,320 | -2,716.1 | -2,040.9 | -836.6 | 257 | -211.1 | 254.8 | 1,626.5 | 478.8 | 2,582.1 | 2,351.3 | 86.47 | 166.67 | 916.22 | 916.58 | -529.22 | -374.06 |
| Net Income
| -4,630 | -6,210 | -2,790 | -2,967.3 | -1,379.5 | -1,945.3 | -6,083 | -1,957.2 | 3,256.6 | 4,049.1 | 8,407.1 | 15,946.9 | 3,427.1 | 905.19 | -10,006.63 | -1,388.58 | 3,858.14 | 3,470.94 | 3,319.13 |
| Net Income Ratio
| -0.165 | -0.234 | -0.087 | -0.11 | -0.049 | -0.047 | -0.155 | -0.049 | 0.073 | 0.09 | 0.174 | 0.284 | 0.074 | 0.024 | -0.222 | -0.039 | 0.145 | 0.201 | 0.235 |
| EPS
| -32.05 | -43.11 | -23.14 | -24.69 | -11.48 | -16.2 | -50.69 | -16.32 | 20.93 | 33.92 | 70.63 | 134.18 | 28.85 | 7.62 | -84.26 | -11.69 | 32.48 | 20.32 | 21.7 |
| EPS Diluted
| -32.05 | -43.11 | -23.14 | -24.69 | -11.48 | -16.12 | -50.1 | -16.13 | 20.78 | 33.53 | 69.77 | 132.09 | 28.71 | 7.62 | -84.26 | -11.69 | 32.48 | 20.31 | 21.68 |
| EBITDA
| 1,560 | 2,230 | 3,010 | -203.5 | 1,325.3 | 1,247.5 | 461.3 | 796.8 | 5,580 | 7,462.8 | 10,641.1 | 20,873 | 14,622.3 | 9,246.29 | 8,598.17 | 8,604.8 | 6,555.5 | 4,574.73 | 3,631.28 |
| EBITDA Ratio
| 0.056 | 0.084 | 0.094 | -0.008 | 0.047 | 0.03 | 0.012 | 0.02 | 0.125 | 0.167 | 0.22 | 0.372 | 0.317 | 0.246 | 0.191 | 0.24 | 0.247 | 0.265 | 0.257 |